Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

Pulmonary arteriovenous malformations: an uncharacterised phenotype of dyskeratosis congenita and related telomere biology disorders

Payal P. Khincha, Alison A. Bertuch, Suneet Agarwal, Danielle M. Townsley, Neal S. Young, Siobán Keel, Akiko Shimamura, Farid Boulad, Tregony Simoneau, Henri Justino, Christin Kuo, Steven Artandi, Charles McCaslin, Des W. Cox, Sara Chaffee, Bridget F. Collins, Neelam Giri, Blanche P. Alter, Ganesh Raghu, Sharon A. Savage
European Respiratory Journal 2017 49: 1601640; DOI: 10.1183/13993003.01640-2016
Payal P. Khincha
1Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: khinchapp@mail.nih.gov
Alison A. Bertuch
2Baylor College of Medicine, Houston, TX, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Suneet Agarwal
3Division of Haematology/Oncology, Boston Children's Hospital, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Danielle M. Townsley
4Hematology Branch, National Heart, Lung, and Blood Institute, NIH, Bethesda, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Neal S. Young
4Hematology Branch, National Heart, Lung, and Blood Institute, NIH, Bethesda, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Siobán Keel
5Division of Haematology, Dept of Medicine, University of Washington, Seattle, WA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Akiko Shimamura
3Division of Haematology/Oncology, Boston Children's Hospital, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Farid Boulad
6Paediatric Oncology and Bone Marrow Transplant Service, Dept of Paediatrics, Memorial Sloan Kettering Cancer Centre, New York, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tregony Simoneau
7Dept of Pulmonology, Connecticut Children's Medical Centre, Hartford, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Henri Justino
2Baylor College of Medicine, Houston, TX, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christin Kuo
8Dept of Pulmonology, Lucile Packard Children's Hospital Stanford, Palo Alto, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Steven Artandi
9Cancer Biology Program, Stanford University School of Medicine, Palo Alto, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charles McCaslin
10Helen DeVos Children's Hospital, Grand Rapids, MI, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Des W. Cox
11Paediatric Respiratory Medicine, Our Lady's Children's Hospital, Dublin, Ireland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sara Chaffee
12Paediatric Haematology Oncology, Children's Hospital at Dartmouth, Dartmouth-Hitchcock Medical Centre, Lebanon, NH, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bridget F. Collins
13Centre for Interstitial Lung Diseases, Division of Pulmonary and Critical Care Medicine/Dept of Medicine, University of Washington, Seattle, WA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Neelam Giri
1Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Blanche P. Alter
1Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ganesh Raghu
13Centre for Interstitial Lung Diseases, Division of Pulmonary and Critical Care Medicine/Dept of Medicine, University of Washington, Seattle, WA, USA
14Both authors contributed equally
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sharon A. Savage
1Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
14Both authors contributed equally
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

PAVMs are underrecognised in telomere biology disorders and present diagnostic and therapeutic challenges http://ow.ly/2lPc304eu0t

To the Editor:

The telomere biology disorder (TBD) dyskeratosis congenita (DC) is a multisystem inherited bone marrow failure syndrome and cancer predisposition syndrome caused by germline mutations in telomere biology genes (DKC1, TINF2, TERC, TERT, NOP10, NHP2, CTC1, WRAP53, ACD, RTEL1 and PARN). The classic triad of reticular skin pigmentation, dysplastic nails and oral leukoplakia is diagnostic of DC [1, 2]. Leukocyte telomere lengths less than the first percentile for age measured by flow cytometry with fluorescence in situ hybridisation are consistent with DC in the presence of other phenotypic features [3]. Pulmonary fibrosis, a known complication of DC/TBD, occurs in ≥20% of patients [1]. Pulmonary arteriovenous malformations (PAVMs) in DC have been previously described in case reports or small case series in the context of hepatopulmonary syndrome (HPS) [4–9]. Presenting features of PAVMs may overlap with those of pulmonary fibrosis, including dyspnoea, orthopnoea, platypnoea, cyanosis and digital clubbing. HPS is described as pulmonary vascular dilatation due to liver disease of any cause (cirrhotic/noncirrhotic with/without portal hypertension), leading to deficient arterial oxygenation [10].

This multi-institutional retrospective review of medical records evaluated patients diagnosed with both DC/TBD and PAVMs. All participants were enrolled in an institutional review board-approved study at the primary reporting institution. Data were received and maintained at the National Cancer Institute (NCI; Bethesda, MD, USA) within the institutional review board-approved Inherited Bone Marrow Failure Syndromes (IBMFS) protocol (NCI02-C-0052, clinicaltrials.gov/ct2/show/NCT00027274) [11]. The study includes patients of any age, sex and race who have been diagnosed with DC/TBD based on clinical criteria and/or genetic testing positive for a known disease-causing mutation.

We report 13 unrelated patients with both DC/TBD and PAVM. Median (range) age at diagnosis of DC/TBD was 13 (1–27) years and at diagnosis of PAVMs was 15 (3–32) years. The male:female ratio was 7:6. The majority (77%) of patients were of European ancestry. Six (46%) patients had germline mutations in TINF2 (table 1). One patient did not have a known causative gene mutation. Data on clinical manifestations at the time of DC/TBD diagnosis were available on 12 patients and are detailed in table 1. 10 (83%) patients had at least one feature of the mucocutaneous triad; all tested patients had very short telomere length for age; and six (50%) had aplastic anaemia. 10 (77%) out of 13 patients underwent haematopoietic cell transplant (HCT) at median (range) age 6 (1–21) years.

View this table:
  • View inline
  • View popup
TABLE 1

Clinical, laboratory and management details of dyskeratosis congenita (DC) and pulmonary arteriovenous malformations (PAVMs) in study participants

The clinical details of PAVM diagnosis and management are also shown in table 1. Two (15%) out of 13 patients had PAVMs diagnosed prior to their diagnosis of DC. Nine (90%) out of 10 patients who underwent HCT had PAVMs diagnosed at a median (range) time interval of 5 (2–8) years after HCT. Notably, two asymptomatic patients had PAVMs diagnosed after evaluation of an unexplained decrease in diffusing capacity of the lung for carbon monoxide (DLCO). Six (46%) patients had pulmonary fibrosis confirmed by computed tomography scan around the time of their PAVM diagnosis. DLCO was reduced (16–56% predicted) out of proportion to other pulmonary function tests and the radiologic extent of pulmonary fibrosis, when present. Transthoracic contrast echocardiography with agitated saline bubble contrast (TTCE) was indicative of a delayed right-to-left shunt (contrast appearing in left heart ≥3 beats after right heart) in 10 (91%) out of 11 patients who underwent TTCE. Two patients who did not undergo TTCE had PAVMs confirmed by abnormal radioisotope lung perfusion scan and/or cardiac catheterisation. Five patients underwent lung perfusion scans that confirmed the presence of right-to-left shunting with tracer uptake in the brain and/or kidney, including the patient with a negative TTCE. Intrapulmonary shunt assessment of arterial blood gases at sea level in one patient showed decreased shunting from sitting upright (arterial oxygen tension (PaO2) 32 mmHg on room air and 102 mmHg on 100% oxygen; 32.8% shunt) to supine posture (PaO2 247 mmHg on 100% oxygen; 21.8% shunt), in concordance with his orthodeoxia and platypnoea. Only patient 5 had PAVMs visible on computed tomography scan and underwent coiling of the same. Her clinical course was complicated by development of a brain abscess 3 months after coiling, attributed to a bacterial embolus consequent to right-to-left shunting. The remaining patients had very small or microscopic PAVMs that were not amenable to transcatheter embolisation. Importantly, nine (69%) out of 13 patients did not have laboratory or radiological evidence of liver disease at the time of PAVM diagnosis.

In summary, this case series establishes PAVMs as a clinically important pulmonary phenotype in DC/TBD and one that may occur in the absence of overt HPS, in the absence of symptoms, and in patients of any age, genotype or phenotype (table 1). The mechanism underlying the development of vascular malformations in patients with aberrant telomere biology is not known. Vascular complications previously reported in DC/TBD have only recently been described as phenotypic features of the DC/TBD spectrum, such as in Revesz syndrome and Coats’ plus [1,9]. Further research is needed to determine whether PAVMs are a consequence of telomere dysfunction; whether they are associated with transforming growth factor-β signalling pathways similar to hereditary haemorrhagic telangiectasia (HHT) [12], an autosomal dominant disease of abnormal angiogenesis; and if any association exists between HCT and PAVMs in DC/TBD.

Timely and accurate diagnosis of PAVMs in DC/TBD is essential for appropriate clinical care and prevention of life-threatening complications (e.g. transient ischaemic attacks, stroke or brain abscesses) caused by paradoxical embolism in the setting of a right-to-left shunt. Multiple diagnostic modalities may be used for the detection of PAVMs including TTCE, DLCO, 6-min walk test and quantification of abnormal physiological shunting by arterial blood gases at sea level. Of these, TTCE is the most sensitive (close to 100% sensitivity reported in HHT) [13]. While pulmonary function tests are nonspecific, isolated decrease in DLCO may indicate abnormal shunting, warranting evaluation for occult PAVMs [14].

This case series reports nine patients with DC/TBD who developed PAVMs in the absence of overt HPS. However, it is not clear whether HPS and PAVMs occur along a continuum as components of one disorder or whether PAVMS can occur without concurrent or future development of liver disease [10]. With no known curative medical treatment options for PAVMs not amenable to transcatheter embolisation, clinicians need to be aware of the therapeutic challenges of PAVMs. Anecdotal reports of agents, including nifedipine and danazol among others have been inconsistent with respect to improvement of symptoms. Lung transplantation, which is an option for PAVMs not surgically treatable, would be unsuccessful if HPS was the underlying cause. In that instance, liver transplantation would be considered and is associated with significant mortality and morbidity [15].

In conclusion, PAVMs are a pulmonary phenotype of DC/TBD that may occur independently of HPS, in asymptomatic patients, across any phenotypic or genotypic presentation. The NCI's IBMFS study includes 145 affected DC patients, of whom seven (5%) were symptomatic of and diagnosed with PAVMs and are included here [11]. We expect that the prevalence of PAVMs in DC/TBD will be higher with formal evaluation of PAVMs across all patients, since PAVMs can occur in the absence of symptoms. Isolated decrease in DLCO and/or hypoxia in DC patients warrant further investigations for PAVM, including TTCE, lung perfusion scan and evaluation of intrapulmonary shunting. Further research on the underlying biological mechanisms, including the pathophysiologic relationship between PAVMs and HPS and therapeutic options are needed to be able to better manage and treat these patients.

Disclosures

Supplementary Material

H. Justino ERJ-01640-2016_Justino

A. Shimamura ERJ-01640-2016_Shimamura

Acknowledgements

This case series is the first completed research effort of the Clinical Care Consortium for Telomere Associated Ailments (CCCTAA), formed in 2013. We thank the patients, their families and the referring clinicians for their valuable contributions to this study.

Footnotes

  • Support statement: This work was supported by the intramural research programme of the National Cancer Institute (Rockville, MD, USA), National Institutes of Health (NIH; Bethesda, MD, USA), the National Heart, Lung and Blood Institute, NIH and the Translational Research Program at Boston Children's Hospital (Boston, MA, USA). Funding information for this article has been deposited with Open Funder Registry.

  • Conflict of interest: Disclosures can be found alongside this article at erj.ersjournals.com

  • Received May 19, 2016.
  • Accepted September 7, 2016.
  • The content of this work is not subject to copyright. Design and branding are copyright ©ERS 2017

References

  1. ↵
    1. Ballew BJ,
    2. Savage SA
    . Updates on the biology and management of dyskeratosis congenita and related telomere biology disorders. Expert Rev Hematol 2013; 6: 327–337.
    OpenUrlCrossRefPubMedWeb of Science
  2. ↵
    1. Bertuch AA
    . The molecular genetics of the telomere biology disorders. RNA Biol 2016; 13: 696–706.
    OpenUrlCrossRefPubMed
  3. ↵
    1. Alter BP,
    2. Baerlocher GM,
    3. Savage SA, et al.
    Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenita. Blood 2007; 110: 1439–1447.
    OpenUrlAbstract/FREE Full Text
  4. ↵
    1. Gordijn SJ,
    2. Brand PL
    . A boy with breathlessness, digital clubbing and central cyanosis. Eur J Pediatr 2004; 163: 129–130.
    OpenUrlCrossRefPubMed
    1. Hirota T,
    2. Yamagami T,
    3. Nakamura T, et al.
    Small pulmonary arteriovenous fistulae revealed by scintigraphy during selective injection of 99Tcm-macroaggregated albumin. Br J Radiol 2004; 77: 445–448.
    OpenUrlAbstract/FREE Full Text
    1. Sands A,
    2. Dalzell E,
    3. Craig B, et al.
    Multiple intrapulmonary arteriovenous fistulas in childhood. Pediatr Cardiol 2000; 21: 493–496.
    OpenUrlCrossRefPubMed
    1. Samuel BP,
    2. Duffner UA,
    3. Abdel-Mageed AS, et al.
    Pulmonary arteriovenous malformations in dyskeratosis congenita. Pediatr Dermatol 2015; 32: e165–e166.
    OpenUrlCrossRefPubMed
    1. Dokal I
    . Dyskeratosis congenita in all its forms. Br J Haematol 2000; 110: 768–779.
    OpenUrlCrossRefPubMedWeb of Science
  5. ↵
    1. Gorgy AI,
    2. Jonassaint NL,
    3. Stanley SE, et al.
    Hepatopulmonary syndrome is a frequent cause of dyspnea in the short telomere disorders. Chest 2015; 148: 1019–1026.
    OpenUrlCrossRefPubMed
  6. ↵
    1. Vettukattil JJ
    . Pathogenesis of pulmonary arteriovenous malformations: role of hepatopulmonary interactions. Heart 2002; 88: 561–563.
    OpenUrlFREE Full Text
  7. ↵
    1. Alter BP,
    2. Giri N,
    3. Savage SA, et al.
    Malignancies and survival patterns in the National Cancer Institute inherited bone marrow failure syndromes cohort study. Br J Haematol 2010; 150: 179–188.
    OpenUrlCrossRefPubMed
  8. ↵
    1. Chung MG
    . Hereditary hemorrhagic telangiactasia. In: Islam MP and Roach ES, eds. Handbook of Clinical Neurology. Amsterdam, Elsevier, 2015; pp. 185–197.
  9. ↵
    1. Faughnan ME,
    2. Palda VA,
    3. Garcia-Tsao G, et al.
    International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia. J Med Genet 2011; 48: 73–87.
    OpenUrlAbstract/FREE Full Text
  10. ↵
    1. Gossage JR,
    2. Kanj G
    . Pulmonary arteriovenous malformations. A state of the art review. Am J Resp Crit Care Med 1998; 158: 643–661.
    OpenUrlCrossRefPubMedWeb of Science
  11. ↵
    1. Swanson KL,
    2. Wiesner RH,
    3. Krowka MJ
    . Natural history of hepatopulmonary syndrome: impact of liver transplantation. Hepatology 2005; 41: 1122–1129.
    OpenUrlCrossRefPubMedWeb of Science
View Abstract
PreviousNext
Back to top
View this article with LENS
Vol 49 Issue 1 Table of Contents
European Respiratory Journal: 49 (1)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Pulmonary arteriovenous malformations: an uncharacterised phenotype of dyskeratosis congenita and related telomere biology disorders
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Pulmonary arteriovenous malformations: an uncharacterised phenotype of dyskeratosis congenita and related telomere biology disorders
Payal P. Khincha, Alison A. Bertuch, Suneet Agarwal, Danielle M. Townsley, Neal S. Young, Siobán Keel, Akiko Shimamura, Farid Boulad, Tregony Simoneau, Henri Justino, Christin Kuo, Steven Artandi, Charles McCaslin, Des W. Cox, Sara Chaffee, Bridget F. Collins, Neelam Giri, Blanche P. Alter, Ganesh Raghu, Sharon A. Savage
European Respiratory Journal Jan 2017, 49 (1) 1601640; DOI: 10.1183/13993003.01640-2016

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Pulmonary arteriovenous malformations: an uncharacterised phenotype of dyskeratosis congenita and related telomere biology disorders
Payal P. Khincha, Alison A. Bertuch, Suneet Agarwal, Danielle M. Townsley, Neal S. Young, Siobán Keel, Akiko Shimamura, Farid Boulad, Tregony Simoneau, Henri Justino, Christin Kuo, Steven Artandi, Charles McCaslin, Des W. Cox, Sara Chaffee, Bridget F. Collins, Neelam Giri, Blanche P. Alter, Ganesh Raghu, Sharon A. Savage
European Respiratory Journal Jan 2017, 49 (1) 1601640; DOI: 10.1183/13993003.01640-2016
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Disclosures
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • Interstitial and orphan lung disease
  • Pulmonary vascular disease
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

Agora

  • Airway immune responses to COVID-19 vaccination in COPD patients
  • Wider access to rifapentine-based regimens is needed for TB care globally
  • Association between immunosuppressants and outcomes of COVID-19
Show more Agora

Research letters

  • Mitochondrial DNA as biomarker of survival in RA-ILD
  • Lung transplantation for cystic fibrosis before and after availability of elexacaftor/tezacaftor/ivacaftor
  • Elexacaftor-tezacaftor-ivacaftor and circulating neutrophil counts in CF
Show more Research letters

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society